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Delirium poses a significant burden on our healthcare, with patients in the intensive care unit (ICU) at an increased risk for 
developing this disorder. In addition, the ICU environment poses unique challenges in the assessment of delirium. It is paramount 
that the healthcare provider has an understanding of delirium in ICU, and monitors for it vigilantly. There have been various 
scoring systems developed to assist in this regard. However, the most commonly used and validated tools for the assessment of 
delirium are the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) and the Intensive Care Delirium Screening 
Checklist (ICDSC). Biomarkers of delirium are emerging as tools to diagnose delirium, stratify severity, monitor progress, and 
predict outcomes, potentially changing the way we approach delirium in the future.
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Introduction
Delirium is a prevalent problem in the intensive care unit (ICU),1–4 
with an associated significant morbidity and mortality.5–8 In the 
South African context, data are scarce but it appears that the face 
of delirium differs from our First World counterparts.9,10 Thus 
vigilant screening and accurate diagnosis of delirium is 
paramount for good medical care. This article will take a brief 
look at delirium itself, and then discuss the methods and issues 
for the assessment of delirium in ICU.
Understanding delirium
Delirium is defined by the Diagnostic and Statistical Manual 5th 
edition (DSM-5) as a fluctuating change in attention, awareness 
and cognition that develops over hours to days.4 The affected 
individuals exhibit labile emotions and disordered behaviour 
including absent cooperation with medical staff, removing 
catheters or lines, and attempts to escape medical care. Their 
symptoms often worsen at night due to limited external stimuli, 
and delirious patients exhibit sleep–wake cycle disturbances. 
Importantly, the condition cannot be explained by an underlying 
neurocognitive disorder, and delirium cannot be diagnosed in a 
comatose state as the diagnosis does require a response from a 
verbal cue.1,4,11 The DSM-5 diagnostic criteria are summarised in 
Table 1.
The incidence of delirium in the intensive care setting varies from 
7% to 87%. This marked discrepancy exists as there are differences 
in studies done with regard to population characteristics, type of 
ICU used (medical, surgical, both), study methodology, 
assessment tool used for diagnosis of delirium, staff training, 
medications used and individual ICU practices.1–3 There are few 
data on the prevalence or incidence of delirium in South Africa, 
but the studies done have shown a wide variation.9,10,12 In a 
systemic review of studies done in sub-Saharan Africa, delirium 
was found most commonly in the 17–65 years age range, which 
contrasts with the usual predominance in the elderly.9 There was 
a high association of delirium with infections, particularly the 
human immunodeficiency virus (HIV). This was further reinforced 
by a psychiatry study done in a Johannesburg hospital where 
most of the medical referrals were due to delirium, with HIV 
being the most common underlying factor.10 The differing 
characteristics have led authors to postulate that the spectrum 
of delirium will differ in sub-Saharan Africa as compared with 
developed countries.9,10
Pathophysiology and risk factors
The pathophysiology of delirium is poorly understood, but is 
likely to be multi-factorial as several risk factors are usually 
present in one patient, and there is considerable overlap in the 
various mechanisms of action.13,14 The pathogenesis may differ 
from case to case with different causes being present.1 Some 
theories on delirium pathophysiology are presented in Table 2.
Delirium is a significant problem in ICU due to the increased 
number of risk factors present in these patients compared with 
non-ICU patients.1,14 By identifying these features, one may be 
alerted to the possibility of a patient developing delirium. It is, 
however, possible to develop delirium despite no predisposing 
traits.22 Predisposing elements may be thought of as those 
relating to the patient’s medical condition, those relating to the 
surgery if done, and those relating to the ICU stay. This is outlined 
in Table 3.
Assessing delirium
Morbidity and mortality with delirium is significant with elevated 
in-hospital mortality, higher incidence of self-extubation and 
removal of catheters, greater need for re-intubation, worsened 
functional and cognitive decline, and increased costs.4–8 However, 
timely diagnosis and management may curtail the duration and 
associated morbidity and mortality of delirium.4,11
One must note that the diagnosis of delirium in ICU might go 
unrecognised due to: inadequate bedside assessment; poor 
knowledge of delirium by medical staff; symptoms attributed to 
other disorders such as dementia; few direct monitors of the 
central nervous system; assessment of delirium impaired by lack 
of verbal contact due to need for ventilation, sedatives or opiates; 
presence of the hypoactive form of delirium.4,11,13,14,18,23, 7 Brummel 
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vigilant screening and accurate diagnosis of delirium is 
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Understanding delirium
Delirium is defined by the Diagnostic and Statistical Manual 5th 
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7% to 87%. This marked discrepancy exists as there are differences 
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but the studies done have shown a wide variation.9,10,12 In a 
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was found most commonly in the 17–65 years age range, which 
contrasts with the usual predominance in the elderly.9 There was 
a high association of delirium with infections, particularly the 
human immunodeficiency virus (HIV). This was further reinforced 
by a psychiatry study done in a Johannesburg hospital where 
most of the medical referrals were due to delirium, with HIV 
being the most common underlying factor.10 The differing 
characteristics have led authors to postulate that the spectrum 
of delirium will differ in sub-Saharan Africa as compared with 
developed countries.9,10
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likely to be multi-factorial as several risk factors are usually 
present in one patient, and there is considerable overlap in the 
various mechanisms of action.13,14 The pathogenesis may differ 
from case to case with different causes being present.1 Some 
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Morbidity and mortality with delirium is significant with elevated 
in-hospital mortality, higher incidence of self-extubation and 
removal of catheters, greater need for re-intubation, worsened 
functional and cognitive decline, and increased costs.4–8 However, 
timely diagnosis and management may curtail the duration and 
associated morbidity and mortality of delirium.4,11
One must note that the diagnosis of delirium in ICU might go 
unrecognised due to: inadequate bedside assessment; poor 
knowledge of delirium by medical staff; symptoms attributed to 
other disorders such as dementia; few direct monitors of the 
central nervous system; assessment of delirium impaired by lack 
of verbal contact due to need for ventilation, sedatives or opiates; 
presence of the hypoactive form of delirium.4,11,13,14,18,23, 7 Brummel 
58  Southern African Journal of Anaesthesia and Analgesia 2017; 23(3):57–63
Table 1: Summary of DSM-5 criteria4
Diagnostic criteria:
(a)  Disturbance in attention (in terms of ability to direct, focus, sustain, or shift attention) and reduced awareness or orientation
(b)  Occurs over a short time period (hours to days), fluctuates during the day, and is an alteration from the patient’s pre-existing functioning
(c)  Disturbance in cognition (memory, orientation, language, visual-spatial ability, or perception)
(d)  The above is found to be the direct result of a medical condition, substance intoxication or withdrawal, toxin, or a combination of factors
Specified subtypes:
(1)  Acute – delirium present for a few hours to days
(2)  Persistent – delirium present for weeks to months
(3)  Hyperactive – increased level of psychomotor activity evident by labile mood, agitation, or refusal to cooperate
(4)  Hypoactive – decreased level of psychomotor activity evident by sluggishness or lethargy
(5)  Mixed level of activity – normal level of psychomotor activity but with disturbances in attention and awareness, which may fluctuate
Table 2: Pathophysiology of delirium1,2,5,13–21
Theory Supporting data
Cerebral inflammation •  May be a response to infection, a risk factor for delirium
•  Inflammatory mediators are able to cross the blood–brain barrier, increase endothelial permeability, 
reduce cerebral blood flow by inducing micro-aggregates or vasoconstriction, and interfere with 
neurotransmitters




•  Acetylcholine is involved in awareness and attention
•  Anticholinergic drugs may be a risk factor for delirium and cholinesterase inhibitors may reduce the duration 
of delirium
Serotonin excess •  Serotonin is associated with learning and memory
•  Selective serotonin reuptake inhibitors are associated with delirium
GABA increase •  Inflammation up-regulates GABAA receptors, promoting neural inhibition
•  Benzodiazepines promote delirium
Dopamine excess •  Increased uptake of substrate amino acids (tryptophan, phenylalanine, tyrosine) could lead to increased 
production of dopamine and noradrenaline
•  Hypoxia and opioids, which are risk factors for delirium, increase dopamine
Cerebral hypoperfusion •  Neuroimaging has found reduced cerebral blood flow in delirious patients
•  Microcirculation abnormalities have been documented in delirium
Cerebral hypoxaemia •  Reduced oxidative metabolism with cerebral slowing shown on EEG
•  Microglial activation due to ischaemic hypoxia leads to a pro-inflammatory response, aggravating the cerebral 
inflammatory response and delirium
Genetic •  Alterations in apolipoprotein E
Table 3: Risk factors for delirium in ICU1–3,5,13–16,18,23–26
Key: HIV = human immunodeficiency virus; APACHE = Acute Physiology and Chronic Health Evaluation; AAA = abdominal aortic aneurysm; 
CABG = coronary artery bypass grafting; ENT = ear, nose and throat; NGT = nasogastric tube; CVC = central venous catheter.
Patient-related Surgery-related ICU-related
•  Age greater than 70 years
•  Co-morbidities (visual, hearing, 
depression, dementia, epilepsy, 
cerebrovascular disease, conges-
tive heart failure, respiratory/re-
nal/liver dysfunction, infections 
such as HIV)
•  Alcohol and psychoactive drug 
abuse
•  Malnutrition and dehydration
•  Greater severity of illness as indi-
cated by an illness severity scor-
ing system (such as APACHE)
•  Sepsis
•  Emergency surgery
•  Surgery type: hip fracture, vascular (AAA, peripheral 
vascular), cardiac (CABG, valvular), major abdominal, 
major ENT, urological, thoracic
•  Longer duration of surgery
•  Intraoperative blood loss, blood transfusions, haema-
tocrit drop to less than 30%
•  Fluctuations in partial pressure of oxygen
•  Intraoperative hypothermia
•  Disruption of sleep cycle
•  Metabolic or electrolyte abnormalities (acidosis, glu-
cose, sodium)
•  Physical restraints and immobilisation
•  Catheters (NGT, bladder, rectal, CVC)





•  Prolonged ventilation
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et al. argue that due to this important association of delirium 
with increased morbidity and mortality, delirium monitoring 
should be as routine as measuring the patient’s blood pressure 
or heart rate.28
Scoring systems
The gold standard assessment of delirium is by a geriatrician, 
neurologist or psychiatrist.29 However, in the ICU setting such 
evaluations need to be done at the bedside by the attending 
healthcare staff. Several studies have shown that both intensivists 
and ICU nurses perform poorly when using clinical judgement 
alone, resulting in many missed cases of delirium.28,30,31 Thus 
delirium assessments are usually aided by a scoring system, 
modified for the ICU environment due to the unique challenges 
in this setting as elucidated above. Assessments done in ICU 
need to be non-verbal, easy to use, short, and able to be done 
without psychiatric training.2
In order to assess delirium, the patient must have an adequate 
level of arousal or responsiveness.28 Thus level of consciousness 
must be measured using scales such as Richmond Agitation–
Sedation Scale or Riker Sedation–Agitation Scale.28,32
The Richmond Agitation and Sedation Scale (RASS) has a 
10-point scale with four levels denoting agitation (+1 to +4), one 
level denoting a calm and alert state (0), and five to assess 
sedation (–1 to –5).33 For the assessment of delirium to be 
possible, the patient must at least be rousable to voice, usually 
by stating the patient’s name, without the need for physical 
stimulation (RASS of at least –3).34
The Sedation–Agitation Scale (SAS) developed by Riker uses 
seven categories for differing severity of sedation or agitation. 
The categories used are: dangerous agitation, very agitated, 
agitated, calm and cooperative, sedated, very sedated, and 
unable to rouse. Although less commonly used, this scale has 
been validated for use in ICU.35,36 For assessment of delirium, the 
SAS should be 3 or more.28
Several scoring systems have been developed for delirium 
assessment and tested in ICU. These include, but are not limited 
to, the Confusion Assessment Method for the Intensive Care Unit 
(CAM-ICU), the Intensive Care Delirium Screening Checklist 
(ICDSC), the Neelon and Champagne (NEECHAM) Confusion 
Scale, the Nursing Delirium Screening Scale (Nu-DESC), the 
Cognitive Test for Delirium (CTD), and the Delirium Detection 
Score (DDS).28,37–39
The CAM-ICU and ICDSC are most widely used, as well as being 
validated for use in intubated (and therefore non-verbal) 
patients.28,32 Both scores have high sensitivity, specificity, and 
inter-rater reliability, and are recommended by the 2013 Society 
of Critical Care Medicine ‘Clinical Practice Guidelines for the 
Management of Pain, Agitation, and Delirium in Adult Patients in 
the Intensive Care Unit’.32 Thus there will be only a brief 
explanation of the other scoring systems already mentioned in 
Table 4.
Confusion Assessment Method for the Intensive 
Care Unit (CAM-ICU)
The CAM-ICU scoring system has been developed from the 
standard Confusion Assessment Method (CAM) scoring system, 
which was developed and validated in general medical wards 
and based on DSM-IIIR criteria.28,40–42 CAM-ICU utilises four 
features of delirium for diagnosis, namely: an acute alteration or 
fluctuation in mental status, inattention, altered level of 
consciousness, and disorganised thinking (See Figure 1).40,41,43
An acute change or fluctuation in mental status is assessed from 
baseline or any change within the past 24 h. This criterion has a 
simple yes or no answer. Inattention is assessed by asking the 
patient to squeeze the investigator’s hand when the letter ‘A’ is 
read in a 10-letter sequence, allowing for a maximum of two 
errors. Any discrepancies can be confirmed with a visual test. 
Altered level of consciousness is assessed by using that patient’s 
current RASS or SAS score. Lastly, disorganised thinking is assessed 
by the patient’s ability to answer four ‘yes/no’-type questions as 
well as obey a command.28,43 If the first two steps already indicate 
the absence of delirium, the scoring system does not have to be 
done to completion, thus shortening the time required.28
Delirium is diagnosed when altered mental state and inattention 
are present, as well as disorganised thinking or altered level of 
consciousness.40 CAM-ICU may be conducted by any trained 
health professional and each assessment takes less than 5 min to 
complete.28,34,37,41 CAM-ICU has a sensitivity of 93% and specificity 
of 89%, as well as high inter-rater reliability demonstrated by 
data from several studies.41,44 Reliability and validity has been 
assessed extensively against the DSM criteria for delirium.28 The 
CAM-ICU scoring system has been found to be easy to understand 
and use.38
However, the CAM-ICU tool does not allow for the assessment of 
the delirium subtype.43 Also it represents only a point in time. 
Thus, to avoid missing delirium, clinicians should perform a 
CAM-ICU assessment several times daily.28,43,45 Another factor to 
consider is that patient cooperation is required to use this scoring 
tool.28,38
Intensive Care Delirium Screening Checklist (ICDSC)
The ICDSC is an 8-item checklist based on the DSM IV delirium 
criteria, evaluated over a period of 8 to 24 h.43,47 These include: 
level of consciousness (which may be given a RASS or SAS score), 
inattention (difficulty following commands, or easily distracted 
by external stimuli, or difficulty in shifting focus), disorientation 
(for place, time or person), hallucinations/delusions/psychosis, 
psychomotor agitation or retardation, inappropriate speech or 
mood, sleep/wake cycle disturbances, and symptom fluctuation 
over 24 h. One point is given for each symptom present in the 
specified time period, with a score greater than 3 signifying 
delirium (See Figure 2).28,43,46
The ICDSC may be conducted by non-specialist staff and each 
assessment takes approximately 7 to 10 min to complete.34 
Unlike CAM-ICU where the patient’s involvement is required, the 
patient’s involvement in the evaluation with the ICDSC is 
passive.44 The ICDSC is also easy to incorporate into daily practice, 
as it utilises data used during daily patient care.45,47 This scoring 
system also has the advantage of being able to diagnose 
subsyndromal delirium, as indicated by a score of 1–3.43,46,48
The ICDSC has greater sensitivity than CAM-ICU (99%) but lower 
specificity (64%).5 The lower specificity may be due to the fact 
that the original validation study did not exclude patients in 
comas or with conditions which may mimic delirium.43,47 Level of 
consciousness is considered the point on the checklist most 
likely to be incorrectly scored by inexperienced observers, and 
Bergeron et al. wrote that this weakens the scale to an extent.47 
The symptom definitions have been found to require further 
clarification and validation.28,43,47
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passive.44 The ICDSC is also easy to incorporate into daily practice, 
as it utilises data used during daily patient care.45,47 This scoring 
system also has the advantage of being able to diagnose 
subsyndromal delirium, as indicated by a score of 1–3.43,46,48
The ICDSC has greater sensitivity than CAM-ICU (99%) but lower 
specificity (64%).5 The lower specificity may be due to the fact 
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(NHLS). Private costs for both NSE and S100B by Ampath 
laboratories are ZAR317.50 each (personal correspondence). 
Costs of running these tests need to be weighed against the cost 
of interventions avoided as a result of their use. There has been 
particular interest in looking at inflammatory markers as well as 
the neuroprotein NSE and S100B protein, and these will be 
briefly discussed further.
Inflammatory biomarkers
Studies on inflammatory biomarkers have looked at various 
cytokines and chemokines.56 A study by Van Boogaard et al. divided 
patients into two groups, namely ‘inflamed’ (possessing a positive 
culture in a specimen of any origin, requiring antibiotics, or with 
more than two criteria of the systemic inflammatory response 
syndrome) and ‘non-inflamed’ (absence of the above). Of the 
inflammatory markers measured, in the inflamed group a raised 
level of interleukin-8 was associated with delirium. In the non-
inflamed group raised interleukin-10 as well as amyloid-β levels 
were associated with delirium. The latter, amyloid-β, was associated 
with long-term cognitive failure, highlighting a role in differentiating 
between the two groups.53 Ritter et al. in a prospective cohort study 
also managed to demonstrate that biomarkers involved in sepsis 
independently predicted the presence of delirium.57
CAM-ICU has been demonstrated by Van Eijk et al. to have better 
diagnostic accuracy than ICDSC,46 whereas another study by 
Plaschke shows high agreement between the two.45 Sensitivity 
of CAM-ICU has been shown to be lower with bedside nurses 
compared with research nurses, highlighting the importance of 
training when scoring systems are implemented in clinical 
practice.28,43,49 It has been noted that emphasis should be placed 
on the consistent, regular and reliable use of either CAM-ICU or 
ICDSC, rather than the differences between them.43
Biomarkers
Biomarkers may provide an important step not only in improving 
our diagnosis of delirium, but also in monitoring progression, 
assessing severity, predicting long-term outcomes, and better 
understanding the pathophysiology of delirium.53,54 The ideal 
biomarker would be specific for the brain, cheap, easy to 
measure, resistant to metabolism, unaffected by renal clearance, 
and have high sensitivity and specificity for diagnosis and 
outcome.55 For all biomarkers, the timing of testing may be 
challenging given the fluctuating course inherent to delirium.56 
Another important consideration is cost. At the time of writing, 
neither neuron-specific enolase (NSE) nor S100B protein tests are 
processed by the South Africa National Health Laboratory Service 
Table 4: Other delirium scoring instruments28,32,34,37,38,44,50–52
Scoring system Abbreviated title Items utilised Scoring of delirium Disadvantages 
Neelon and Champagne Confu-
sion Scale
NEECHAM Information processing: 
attention, following commands, 
orientation
Scores range from 0 (minimal 
responsiveness) to 30 (normal 
function)
Little validation against DSM 
criteria for delirium
Behaviour: appearance, motor, 
verbal
Delirium diagnosed with score 
below 20
Not developed for critical care 
patients
Physiological parameters: vital 
signs, oxygen saturation, urinary 
incontinence
Unable to use in intubated 
patients
Nursing Delirium Screening Scale Nu-DESC Disorientation Each item rated a score of 0 to 2 Developed for general medical 
patients, little validation for 
ICU use
Inappropriate behaviour Maximum score of 10 Sedation not accounted for
Inappropriate communication Delirium diagnosed with a score 
of 2 or more
Higher incidence of false-pos-
itive results due to diagnosing 
prodromal symptoms as delirium 
Hallucination
Psychomotor retardation
Cognitive Test for Delirium CTD Orientation Each item scored from 0 to 6 Designed for research assistants
Attention Maximum score of 30 Takes 10–15 min to complete
Memory Delirium diagnosed with a score 
below 19




Delirium Detection Score DDS Agitation Varying points assigned to each 
item
Low validation against DSM 
criteria for delirium
Anxiety Maximum score of 56 Symptoms monitored during the 
course of a shift, increasing the 
time for scoring
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transporters, exposing the brain to potentially toxic metabolites.57 
Also, inflammatory markers may arise due to complex 
relationships with neurotransmitters implicated in delirium.58
Neuron-specific enolase biomarker
Neuron-specific enolase (NSE) is an intra-cytoplasmic enzyme 
found predominantly in neurons and neuroendocrine tissue.56 It 
catalyses the conversion of 2-phospho-D-glycerate to 
phosphoenolpyruvate in the glycolytic pathway. Thus levels of 
NSE will be elevated when cells in the aforementioned tissues 
rupture. The enzyme, which has molecular weight of 78 kDa, has 
a half-life of 24 h (in comparison with the shorter half-life of the 
S100B protein).56 However, several issues have resulted in 
conflicting results as to whether NSE may predict poor 
neurological outcomes, as contamination from non-neural 
sources of the enzyme, hypothermia, and individual differences 
caused by genetic polymorphisms may alter findings.55 
Additionally, major injury to the central nervous system such as 
ischaemic stroke, traumatic brain injury, temporal lobe epilepsy, 
and neurosurgery may cause the release of NSE independent of 
delirium.55,58 Studies specifically pertaining to NSE and delirium 
have inconsistent results, and it has been suggested that 
neuronal injury markers such as NSE have more value in 
However, there have been inconsistencies between studies in 
terms of which inflammatory markers to use.53,57,58 One must keep 
in mind that there may not be a direct effect of cytokines on brain 
function, but rather that inflammation alters the permeability of 
the blood–brain barrier and inhibits certain specific drug efflux 
Figure 2: ICDSC scoring system.47
Figure 1: CAM-ICU scoring system.40
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time in ICU patients. JAMA. 2003;289(22):2983–91. doi:10.1001/
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predicting later dementia in a patient who has suffered an 
episode of delirium.54
S100B biomarker
S100 proteins are cytosolic calcium-binding proteins. The 
subtype of this family of proteins, S100B, is found predominantly 
in astroglial and Swann cells but does exhibit extra-neural 
sources.59 S100B has a half-life of 25 min, but the timing of the 
peak levels depends on the source of the biomarker.60 The precise 
functions of these proteins are unknown, but they are thought to 
be involved in glial and neuronal proliferation and activation.55 
Astrocytes are activated following brain injury and the 
subsequent proliferation results in elevations of S100B proteins, 
which are secreted into the cerebrospinal fluid.55,61 The majority 
that are secreted during and immediately after surgery are due 
to contamination from extra-neural sources.55 Thus elevations of 
this protein more than 24 h after surgery are more indicative of a 
neural cause, and daily serial measurements are recommended.61 
S100B protein elevation has shown promise as a biomarker in a 
variety of neurological disorders, but has shown an inconclusive 
correlation with delirium in small studies.53,62–65
Conclusion
The awareness and assessment of delirium should be an 
important feature in ICU care. The use of an ICU scoring system is 
advocated for this purpose. The CAM-ICU and ICDSC systems are 
both well validated, but the choice between the two is guided by 
clinician preference with emphasis on correct and consistent use 
as part of the daily routine. Regular neural biomarker use is 
undermined by limited supporting literature and cost constraints. 
However, as we continue to study ways to diagnose, monitor and 
essentially understand delirium, so the care of our patients will 
advance.
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